Pharmaceutical
packaging for pharmaceuticals is made from a number of different materials,
including plastics and glass. Most manufacturers will use plastic or glass for
the packaging of their medications since it is the easiest and most
cost-effective option available. However, there are those manufacturers that
use other materials to develop their packaging for pharmaceuticals. Plastic and
glass are used to create 'pressure boxes' and these manufacturers ensure that
the boxes are manufactured to the highest quality standards possible. Each box
is then packed with high-quality cardboard, which ensures that the packaging
will withstand harsh environments.
Stringent
laws and regulations enforced by governments are expected to drive growth of
the global anti-counterfeit pharmaceutical packaging market. The government of
many countries has enforced stringent regulations and laws to curb the
counterfeiting of products. Furthermore, in September 2020, the International
Trademark Association (INTA) announced to step up its efforts to combat
counterfeit products with new laws under consideration. Moreover, in December
2019, in the U.S., the SANTA Act (Stopping All Nefarious Toys in America Act)
was introduced that set requirements for online marketplaces selling toys to
verify seller information and disclose it to consumers. Furthermore, in June
2020, Europol sized over 1,300 tons of fake pesticides, which could fill 458
Olympic-sized pools. Such factors are expected to drive growth of the global anti-counterfeit
pharmaceutical packaging market. Furthermore, rising focus of
manufacturers on brand protection is expected to boost the global
anti-counterfeit pharmaceutical packaging market growth in the near future.
High initial
cost combined with major R&D investment is expected to restrain growth of
the global anti-counterfeit pharmaceutical packaging market. However,
increasing demand from emerging economies and the availability of remote
authentication of products technology can present lucrative growth
opportunities in the global anti-counterfeit pharmaceutical packaging market.
Among regions, North America is expected to witness significant growth in the
global anti-counterfeit pharmaceutical packaging market. This is owing to the
presence of stringent anti-counterfeit laws across the region. Furthermore,
Europe is expected to register a robust growth rate, owing to the presence of
prominent medical and pharmaceutical companies such as AstraZeneca, Johnson
& Johnson, Sanofi, Roche Ltd., and GlaxoSmithKline plc in the region.
Major
companies involved in the global anti-counterfeit pharmaceutical packaging
market are Zebra Technologies, Impinj, Inc., Alien Technology Corp.,
Microtrace, LLC, AlpVision, SICPA HOLDING SA, and Avery Dennison Corp.
For
instance, in September 2019, Toppan Printing collaborated with Amcor to provide
NFC tag-enabled anti-counterfeiting solutions for the wine and spirits market.
The unique, AI monitored, patent pending, cost-effective anti-counterfeit technology offered by NeuroTags renders clones invalid. Companies looking towards eliminating counterfeits of their products from the market are deploying the smart app-less, seamless, and easy-to-use loyalty programs designed by NeuroTags.
ReplyDeleteAnti Counterfeit Packaging